Real-time enrollment status for this myelofibrosis clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 4:21 AM UTC
| NCT Number | NCT01973881 |
| Recruiting Status | Recruiting |
| Condition | Myelofibrosis |
| Phase | Clinical Trial |
| Target Enrollment | 192 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Michigan Rogel Cancer Center |
| Last Updated on CT.gov | August 17, 2025 (Aug 17, 2025) |
As of July 17, 2026: Clinical trial NCT01973881 is currently recruiting participants. This clinical trial study for myelofibrosis is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Michigan Rogel Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT01973881 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT01973881 was last updated Aug 17, 2025 (August 17, 2025). HelloStudys verifies this status automatically.